Cardio toxicity for older breast cancer patients treated with trastuzumab

被引：0
|
作者：
Bensalem, A. [1 ]
Hamdouche, R. [1 ]
Bensehamdi, A. [1 ]
Boudersa, A. [1 ]
Yousfi, N. [1 ]
Bouzid, K. [2 ]
机构：
[1] CHU Dr Benbadis Constantine Algeria, CNE, Constantine, Algeria
[2] CPMC, Algiers, Algeria
来源：
EUROPEAN JOURNAL OF CANCER | 2013年 / 49卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1568
引用
收藏
页码：S343 / S343
页数：1
相关论文
共 50 条
  • [31] New Cardiac Abnormalities After Radiotherapy in Breast Cancer Patients Treated With Trastuzumab
    Nack, Elana
    Koffer, Paul P.
    Blumberg, Charles S.
    Leonard, Kara Lynne
    Huber, Kathryn E.
    Fenton, Mary Anne
    Dizon, Don S.
    Wazer, David E.
    Hepel, Jaroslaw T.
    CLINICAL BREAST CANCER, 2020, 20 (03) : 246 - 252
  • [32] High incidence of cerebral metastases in patients with metastatic breast cancer treated with trastuzumab
    Clayton, A.
    Danson, S.
    Jolly, S.
    Ryder, D.
    Burt, R.
    Stewart, A.
    Wilkinson, P.
    Magee, B.
    Wilson, G.
    Wardley, A.
    EJC SUPPLEMENTS, 2004, 2 (03): : 127 - 127
  • [33] Genomic parameters affecting the outcome of patients with advanced breast cancer treated with trastuzumab
    Gogas, H.
    Kotoula, V.
    Alexopoulou, Z.
    Christodoulou, C.
    Kostopoulos, I.
    Bobos, M.
    Raptou, G.
    Charalambous, E.
    Tsolaki, E.
    Xanthakis, I.
    Pentheroudakis, G.
    Koutras, A.
    Bafaloukos, D.
    Papakostas, P.
    Aravantinos, G.
    Psyrri, A.
    Petraki, K.
    Kalogeras, K. T.
    Fountzilas, G.
    Pectasides, D.
    CANCER RESEARCH, 2016, 76
  • [34] Survival and cardiac toxicity in patients with HER2-positive, metastatic breast cancer treated with trastuzumab in routine clinical practice
    Vasista, Anuradha
    Ryan, Luke
    Naher, Sayeda
    Moylan, Eugene
    Stockler, Martin R.
    Wilcken, Nicholas
    Kiely, Belinda E.
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2020, 16 (01) : 34 - 38
  • [35] Acute Toxicity in Patients With HER2-Positive Breast Cancer Treated With Adjuvant Radiation Therapy and Concurrent Trastuzumab and Pertuzumab
    Spiegel, D.
    Marcom, K.
    Peterson, B.
    Force, J.
    Howie, L.
    Palta, M.
    Blitzblau, R. C.
    Horton, J. K., Sr.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02): : E9 - E10
  • [36] Pharmacogenetic Approach to Toxicity in Breast Cancer Patients Treated with Taxanes
    Angelini, Silvia
    Botticelli, Andrea
    Onesti, Concetta Elisa
    Giusti, Raffaele
    Sini, Valentina
    Durante, Valeria
    Strigari, Lidia
    Gentile, Giovanna
    Cerbelli, Bruna
    Pellegrini, Patrizia
    Sgroi, Valentina
    Occhipinti, Mario
    Di Pietro, Francesca Romana
    Rossi, Alessandro
    Simmaco, Maurizio
    Mazzuca, Federica
    Marchetti, Paolo
    ANTICANCER RESEARCH, 2017, 37 (05) : 2633 - 2639
  • [37] Development of a cardiac toxicity prediction tool for HERZ (+) breast cancer patients receiving trastuzumab
    Sulpher, Jeffrey A.
    Dranitsaris, George
    Crawley, Freya
    Dattilo, Franco
    Kovacs, Maya
    Johnson, Christopher
    Dent, Susan
    CANCER RESEARCH, 2015, 75
  • [38] Trastuzumab Cardiotoxicity in Patients with Breast Cancer
    Freitas, Aguinaldo Figueiredo, Jr.
    Rassi, Salvador
    ARQUIVOS BRASILEIROS DE CARDIOLOGIA, 2014, 102 (02) : 200 - 200
  • [39] Financial toxicity in patients with metastatic breast cancer on trastuzumab deruxtecan (T-DXd)
    Lapen, Kaitlyn
    Dee, Edward Christopher Christopher
    Thom, Bridgette
    Aviki, Emeline Mariam
    Chino, Fumiko
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [40] Cardiac Impairment in Women with Breast Cancer Treated with Trastuzumab
    Germanou, S.
    Adkin, C.
    Assersohn, L.
    Sharma, R.
    Kelleher, M.
    CLINICAL ONCOLOGY, 2015, 27 (06) : E12 - E12
12345